Ignite Creation Date:
2024-05-06 @ 10:40 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03324282
Status:
TERMINATED
Last Update Posted:
2022-05-03
First Post:
2017-10-19
Brief Title:
First-line GemcitabineCisplatin - Avelumab in Locally Advanced or Metastatic Bladder Carcinoma
Sponsor:
Organization:
University Hospital Bordeaux